Buspirone Hydrochloride
Product Images NDC 55111-474

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 55111-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Carton1 (Carton1)
Buspirone Hydrochloride Tablets, USP 5 mg packaging label from Dr. Reddy's Laboratories Limited. The label displays the product name with strength, dosage form as tablets, and notes the NDC 59311-472 for 100 tablets in unit dose packaging (10 unit dose boards with 10 tablets each). It includes storage instructions and states the package is not child resistant. A barcode and manufacturer address in India are visible.*
FDA Label Image

Carton2 (Carton2)

Carton2 (Carton2)
Buspirone Hydrochloride Tablets, USP 10 mg packaging label from Dr. Reddy's Laboratories Limited. The label indicates the product contains 100 tablets divided into 10 blister cards with 10 tablets each. It notes the unit dose packaging, storage instructions, and the manufacturer’s location in India.*
FDA Label Image

Carton3 (Carton3)

Carton3 (Carton3)
Buspirone Hydrochloride Tablets USP 15 mg packaging label from Dr. Reddy's Laboratories Limited. The label indicates each unit-dose package contains 10 tablets, with instructions for storage at 20°-25°C and a caution that the package is not child resistant. The label includes the NDC number 59111-474-78 and states the product is Rx only. The label displays the manufacturer information: Dr. Reddy's Laboratories Limited, Bachepalli, India.*
FDA Label Image

Carton4 (Carton4)

Carton4 (Carton4)
Buspirone Hydrochloride Tablets, USP 30 mg packaging carton from Dr. Reddy's Laboratories Limited. The label specifies each tablet contains 30 mg of buspirone hydrochloride, stored at 20°-25°C, and includes 108 tablets in unit dose form (10 blister cards each containing 10 tablets). The manufacturer's details and NDC 59711-475-78 are also shown.*
FDA Label Image

Container1 (Container1)

Container1 (Container1)
Buspirone Hydrochloride 5 mg tablets label from Dr. Reddy's Laboratories Limited for a package of 100 tablets. The label includes dosage form, strength, tablet count, NDC 55111-472-01, storage instructions, and a barcode.*
FDA Label Image

Container2 (Container2)

Container2 (Container2)
Buspirone Hydrochloride 10 mg tablets label from Dr. Reddy's Laboratories Limited. The label states the product name, strength, dosage form as tablets, and quantity as 100 tablets. It includes NDC 55111-473-01, storage instructions, and packaging details, with a barcode and manufacturer information.*
FDA Label Image

Container3 (Container3)

Container3 (Container3)
Buspirone Hydrochloride Tablets, USP 15 mg packaging label from Dr. Reddy's Laboratories Limited. The label states the product contains 100 tablets, with each tablet containing 15 mg of buspirone hydrochloride. It includes storage instructions and manufacturer details, with the Dr. Reddy's logo visible.*
FDA Label Image

Container4 (Container4)

Container4 (Container4)
Buspirone Hydrochloride Tablets, USP 30 mg label from Dr. Reddy's Laboratories Limited. The label indicates 100 tablets per package. It includes storage instructions and a barcode, with the NDC number 55111-475-01.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
An instructional diagram showing the identification and partial tablet dosing information for Buspirone Hydrochloride 15 mg and 30 mg tablets from Dr. Reddy's Laboratories Limited. It illustrates the front and other sides of each tablet with imprint codes (474 and R DY for 15 mg; 475 and R DY for 30 mg) and provides visual guidance on tablet fractions corresponding to specific doses.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A black-and-white instructional illustration showing two hands holding and twisting open a foil blister pack. The image demonstrates how to peel apart or open the packaging, likely for tablet removal.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Buspirone Hydrochloride showing its molecular framework with ring and chain components, including nitrogen and oxygen atoms, and the HCl component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.